Islet Autoantibodies

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2016 Apr 27

PMID 27112957

Citations 42

Authors

Vito Lampasona

Daniela Liberati

Affiliations

Soon will be listed here.

Abstract

Islet autoantibodies are the main markers of pancreatic autoimmunity in type 1 diabetes (T1D). Islet autoantibodies recognize insulin (IAA), glutamic acid decarboxylase (GADA), protein phosphatase-like IA-2 (IA-2A), and ZnT8 (ZnT8A), all antigens that are found on secretory granules within pancreatic beta cells. Islet antibodies, measured by sensitive and specific liquid phase assays, are the key parameters of the autoimmune response monitored for diagnostics or prognostics in patients with T1D or for disease prediction in at-risk individuals before T1D onset. Islet autoantibodies have been the main tool used to explore the natural history of T1D; this review summarizes the current knowledge about the autoantigens and the phenotype of islets autoantibodies acquired in large prospective studies from birth in children at risk of developing T1D.

Citing Articles

Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN study.

Angiulli S, Merolla A, Borgonovo E, De Lorenzo R, Spadoni S, Fontana B Front Public Health. 2025; 13:1506240.

PMID: 40008147 PMC: 11850345. DOI: 10.3389/fpubh.2025.1506240.

The role of B cells in the pathogenesis of type 1 diabetes.

Wang Y, Li R, Huang Y, Chen H, Nie H, Liu L Front Immunol. 2025; 15():1450366.

PMID: 39776900 PMC: 11703732. DOI: 10.3389/fimmu.2024.1450366.

Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management.

Wang J, Wan K, Chang X, Mao R World J Diabetes. 2024; 15(3):348-360.

PMID: 38591076 PMC: 10999045. DOI: 10.4239/wjd.v15.i3.348.

GAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study.

Hampe C, Shojaie A, Brooks-Worrell B, Dibay S, Utzschneider K, Kahn S J Endocr Soc. 2024; 8(3):bvad179.

PMID: 38333889 PMC: 10853002. DOI: 10.1210/jendso/bvad179.

Teplizumab in Type 1 Diabetes Mellitus: An Updated Review.

Thakkar S, Chopra A, Nagendra L, Kalra S, Bhattacharya S touchREV Endocrinol. 2024; 19(2):22-30.

PMID: 38187075 PMC: 10769466. DOI: 10.17925/EE.2023.19.2.7.

References

Bottazzo G, Florin-Christensen A, Doniach D . Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974; 2(7892):1279-83. DOI: 10.1016/s0140-6736(74)90140-8. View

Williams A, Lampasona V, Schlosser M, Mueller P, Pittman D, Winter W . Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes. Diabetes. 2015; 64(9):3239-46. PMC: 4542444. DOI: 10.2337/db14-1693. View

Mally M, Cirulli V, Otonkoski T, Soto G, Hayek A . Ontogeny and tissue distribution of human GAD expression. Diabetes. 1996; 45(4):496-501. DOI: 10.2337/diab.45.4.496. View

Liu E, Eisenbarth G . Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol. 2007; 125(2):120-6. PMC: 2104491. DOI: 10.1016/j.clim.2007.08.005. View

Thompson W, Pekalski M, Simons H, Smyth D, Castro-Dopico X, Guo H . Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes. Clin Exp Immunol. 2014; 177(3):571-85. PMC: 4137841. DOI: 10.1111/cei.12362. View

Krause S, Chmiel R, Bonifacio E, Scholz M, Powell M, Furmaniak J . IA-2 autoantibody affinity in children at risk for type 1 diabetes. Clin Immunol. 2012; 145(3):224-9. DOI: 10.1016/j.clim.2012.09.010. View

Brooking H, Ananieva-Jordanova R, Arnold C, Amoroso M, Powell M, Betterle C . A sensitive non-isotopic assay for GAD65 autoantibodies. Clin Chim Acta. 2003; 331(1-2):55-9. DOI: 10.1016/s0009-8981(03)00088-3. View

Soderbergh A, Myhre A, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E . Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2004; 89(2):557-62. DOI: 10.1210/jc.2003-030279. View

Gylling M, Tuomi T, Bjorses P, Kontiainen S, Partanen J, Christie M . ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2001; 85(12):4434-40. DOI: 10.1210/jcem.85.12.7120. View

10.

GEPTS W . Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965; 14(10):619-33. DOI: 10.2337/diab.14.10.619. View

11.

Achenbach P, Schlosser M, Williams A, Yu L, Mueller P, Bingley P . Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin Immunol. 2006; 122(1):85-90. DOI: 10.1016/j.clim.2006.09.004. View

12.

Lernmark A, Molenaar J, van Beers W, Yamaguchi Y, Nagataki S, Ludvigsson J . The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories. Diabetologia. 1991; 34(7):534-5. DOI: 10.1007/BF00403293. View

13.

Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E . The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity. 2011; 44(5):394-405. DOI: 10.3109/08916934.2010.540604. View

14.

Bonifacio E, Lampasona V, Bernasconi L, Ziegler A . Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes. 2000; 49(2):202-8. DOI: 10.2337/diabetes.49.2.202. View

15.

Schmidli R, Colman P, Bonifacio E, Bottazzo G, Harrison L . High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes. 1994; 43(8):1005-9. DOI: 10.2337/diab.43.8.1005. View

16.

Fenalti G, Law R, Buckle A, Langendorf C, Tuck K, Rosado C . GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol. 2007; 14(4):280-6. DOI: 10.1038/nsmb1228. View

17.

Martino G, Grimaldi L, Bazzigaluppi E, Passini N, Sinigaglia F, Rogge L . The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients. J Neuroimmunol. 1996; 69(1-2):129-34. DOI: 10.1016/0165-5728(96)00104-x. View

18.

Giannopoulou E, Winkler C, Chmiel R, Matzke C, Scholz M, Beyerlein A . Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia. 2015; 58(10):2317-23. DOI: 10.1007/s00125-015-3672-y. View

19.

Lampasona V, Passerini L, Barzaghi F, Lombardoni C, Bazzigaluppi E, Brigatti C . Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome. PLoS One. 2013; 8(11):e78664. PMC: 3826762. DOI: 10.1371/journal.pone.0078664. View

20.

Bender C, Schlosser M, Christen U, Ziegler A, Achenbach P . GAD autoantibody affinity in schoolchildren from the general population. Diabetologia. 2014; 57(9):1911-8. DOI: 10.1007/s00125-014-3294-9. View